125 related articles for article (PubMed ID: 16671538)
1. [Synthesis of phenyloxyisobutyric acid derivatives and their antidiabetic activity in vitro].
Zeng QL; Wang HQ; Luo H; Gao XP; Liu ZR; Li BG; Wang FP; Zhao YF
Yao Xue Xue Bao; 2006 Feb; 41(2):108-14. PubMed ID: 16671538
[TBL] [Abstract][Full Text] [Related]
2. [Design, synthesis and insulin-sensitizing activity of indole derivatives].
Tang L; Yang YS; Ji RY
Yao Xue Xue Bao; 2006 Mar; 41(3):225-9. PubMed ID: 16758992
[TBL] [Abstract][Full Text] [Related]
3. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship studies of novel 2,4,6-trisubstituted-5-pyrimidinecarboxylic acids as peroxisome proliferator-activated receptor gamma (PPARgamma) partial agonists with comparable antidiabetic efficacy to rosiglitazone.
Seto S; Okada K; Kiyota K; Isogai S; Iwago M; Shinozaki T; Kitamura Y; Kohno Y; Murakami K
J Med Chem; 2010 Jul; 53(13):5012-24. PubMed ID: 20527969
[TBL] [Abstract][Full Text] [Related]
5. [Design and synthesis of a type of benzopyran derivatives with insulin-sensitizing activity].
Tang L; Li Y; Yu JH; Yang YS; Ji RY
Yao Xue Xue Bao; 2008 Jun; 43(6):605-10. PubMed ID: 18822963
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of docosahexaenoic acid derivatives designed as novel PPARgamma agonists and antidiabetic agents.
Itoh T; Murota I; Yoshikai K; Yamada S; Yamamoto K
Bioorg Med Chem; 2006 Jan; 14(1):98-108. PubMed ID: 16198578
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and biological activity of a series of benzopyran derivatives].
Tang L; Yang YS; Ji RY
Yao Xue Xue Bao; 2008 Feb; 43(2):162-8. PubMed ID: 18507343
[TBL] [Abstract][Full Text] [Related]
8. Homoisoflavonoids from the fibrous roots of Polygonatum odoratum with glucose uptake-stimulatory activity in 3T3-L1 adipocytes.
Zhang H; Yang F; Qi J; Song XC; Hu ZF; Zhu DN; Yu BY
J Nat Prod; 2010 Apr; 73(4):548-52. PubMed ID: 20158245
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
Pingali H; Jain M; Shah S; Makadia P; Zaware P; Goel A; Patel M; Giri S; Patel H; Patel P
Bioorg Med Chem; 2008 Aug; 16(15):7117-27. PubMed ID: 18625559
[TBL] [Abstract][Full Text] [Related]
10. Induction of adiponectin by natural and synthetic phenolamides in mouse and human preadipocytes and its enhancement by docosahexaenoic acid.
Yamazaki Y; Kawano Y; Uebayasi M
Life Sci; 2008 Jan; 82(5-6):290-300. PubMed ID: 18166202
[TBL] [Abstract][Full Text] [Related]
11. [Design, synthesis and insulin-sensitizing activity of some peroxisome proliferator-activated gamma agonists].
Zhong CB; Zhu XJ; Liu ZR; Gao XP; Wang XC
Yao Xue Xue Bao; 2005 Feb; 40(2):136-40. PubMed ID: 15875669
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
Fang XK; Gao J; Zhu DN
Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
[TBL] [Abstract][Full Text] [Related]
13. Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
Humphries PS; Almaden JV; Barnum SJ; Carlson TJ; Do QQ; Fraser JD; Hess M; Kim YH; Ogilvie KM; Sun S
Bioorg Med Chem Lett; 2006 Dec; 16(23):6116-9. PubMed ID: 16979341
[TBL] [Abstract][Full Text] [Related]
14. Insulin-sensitizing effects of a novel alpha-methyl- alpha -phenoxylpropionate derivative in vitro.
Wu HS; Yu JH; Li YY; Yang YS; He QJ; Lou YJ; Ji RY
Acta Pharmacol Sin; 2007 Mar; 28(3):417-22. PubMed ID: 17303006
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
[TBL] [Abstract][Full Text] [Related]
16. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
Allen T; Zhang F; Moodie SA; Clemens LE; Smith A; Gregoire F; Bell A; Muscat GE; Gustafson TA
Diabetes; 2006 Sep; 55(9):2523-33. PubMed ID: 16936200
[TBL] [Abstract][Full Text] [Related]
17. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
[TBL] [Abstract][Full Text] [Related]
19. Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists.
Erbe DV; Gartrell K; Zhang YL; Suri V; Kirincich SJ; Will S; Perreault M; Wang S; Tobin JF
Vascul Pharmacol; 2006 Sep; 45(3):154-62. PubMed ID: 16765099
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and insulin-sensitizing activity of indomethacin and diclofenac derivatives.
Zhang J; Wang J; Wu H; He Y; Zhu G; Cui X; Tang L
Bioorg Med Chem Lett; 2009 Jun; 19(12):3324-7. PubMed ID: 19423341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
